Nov 2nd, 2009 - Reuters
Related topics:
* Label changes for Lilly-Amylin diabetes drug
* FDA says reports represent small percentage of patients
NEW YORK, Nov 2 (Reuters) - Patients and doctors should beaware of possible kidney function problems with Eli Lilly(LLY.N) and Amylin Pharmaceuticals' (AMLN.O) Byetta diabetesdrug, U.S. health regulators said on Monday.
The U.S. Food and Drug Administration received 78 reportsof problems with kidney function in patients using Byetta fromApril 2005 through October 2008.
Related stories:
Diet Sodas May Be Hard on the Kidneys
Nov 2nd, 2009 - WebMD
Nov. 2, 2009 -- Diet soda may help keep your calories in check, butdrinking two or more diet sodas a day may double your risk of declining kidneyfunction, a new study shows.
Stroke risk linked to anemia drug, study finds
Oct 30th, 2009 - MSNBC
A new study raises fresh safety concerns about widely used anemia medicines, finding that the drug Aranesp nearly doubled the risk of stroke in people with diabetes and chronic kidney problems who are not yet sick enough to need dialysis.
